A detailed history of Anchyra Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Anchyra Partners LLC holds 4,055 shares of BSX stock, worth $416,407. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,055
Holding current value
$416,407
% of portfolio
0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$94.95 - $104.98 $385,022 - $425,693
4,055 New
4,055 $387 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Anchyra Partners LLC Portfolio

Follow Anchyra Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchyra Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchyra Partners LLC with notifications on news.